Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Neumora Launches With $500m To Advance Personalized Neuroscience Drugs
Funding Includes $100m Under New Amgen Deal
Oct 07 2021
•
By
Mandy Jackson
Neumora raised more than $400m to build the company at scale and develop multiple programs at once • Source: Alamy
More from Financing
More from Business